Ipsilateral axillary lymphadenopathy after COVID-19 vaccination in a young female; a case report and literature review
-
Published:2022-12-07
Issue:6
Volume:26
Page:820-823
-
ISSN:2220-5799
-
Container-title:Anaesthesia, Pain & Intensive Care
-
language:
-
Short-container-title:Anaesth. pain intensive care
Author:
Perveen Wajida,Butt Maryam Naseer,Malik Sarosh,Raja Sohail Khan,Feroz Rabia,Asif Roha
Abstract
It has been two years since vaccination for COVID-19 was launched worldwide. In Pakistan, the vaccination started in the beginning of 2020. Since then several side effects were reported after vaccination, including soreness of the arm, fever, chills, malaise and diarrhoea. Axillary lymphadenopathy has been found to be associated with several conditions that include autoimmune disorders, infections, malignancy and some idiopathic causes. We present a rare case of a 30 y old female with recent recovery from COVID-19, who developed ipsilateral axillary lymphadenopathy after 15 days of Sinovac vaccination. Ultrasonography was done to confirm the diagnosis and its spread towards breast and cervical region. This case report discusses some key points and recommendations regarding unilateral axillary lymphadenopathy after COVID-19 vaccination.
Key words: COVID-19; Lymphadenopathy; vaccination; Pakistan
Citation: Butt MN, Perveen W, Malik S, Raja SK, Feroz R, Asif R. Ipsilateral axillary lymphadenopathy after COVID-19 vaccination in a young female; a case report and literature review. Anaesth. pain intensive care 2022;26(6):815−818. DOI: 10.35975/apic.v26i6.2066
Publisher
Aga Khan University Hospital
Subject
Anesthesiology and Pain Medicine,Critical Care and Intensive Care Medicine